
### [MONDO:0000653](http://purl.obolibrary.org/obo/MONDO_0000653)
**Label:** integumentary system cancer

**Subclasses:** [MONDO:0015873](http://purl.obolibrary.org/obo/MONDO_0015873) (Paget disease of the nipple), [MONDO:0019317](http://purl.obolibrary.org/obo/MONDO_0019317) (follicular atrophoderma-basal cell carcinoma), [MONDO:0015633](http://purl.obolibrary.org/obo/MONDO_0015633) (Bazex syndrome), [MONDO:0016287](http://purl.obolibrary.org/obo/MONDO_0016287) (adenoid basal carcinoma of the cervix uteri), [MONDO:0000930](http://purl.obolibrary.org/obo/MONDO_0000930) (nodular malignant melanoma), [MONDO:0006119](http://purl.obolibrary.org/obo/MONDO_0006119) (breast mucosa-associated lymphoid tissue lymphoma), [MONDO:0006117](http://purl.obolibrary.org/obo/MONDO_0006117) (breast diffuse large b-cell lymphoma), [MONDO:0003520](http://purl.obolibrary.org/obo/MONDO_0003520) (malignant acrospiroma), [MONDO:0003087](http://purl.obolibrary.org/obo/MONDO_0003087) (breast mucoepidermoid carcinoma), [MONDO:0003880](http://purl.obolibrary.org/obo/MONDO_0003880) (ceruminous carcinoma), [MONDO:0003881](http://purl.obolibrary.org/obo/MONDO_0003881) (vulvar apocrine adenocarcinoma), [MONDO:0002671](http://purl.obolibrary.org/obo/MONDO_0002671) (breast signet ring cell adenocarcinoma), [MONDO:0005023](http://purl.obolibrary.org/obo/MONDO_0005023) (ductal breast carcinoma in situ), [MONDO:0004053](http://purl.obolibrary.org/obo/MONDO_0004053) (Bartholin's gland squamous cell carcinoma), [MONDO:0015758](http://purl.obolibrary.org/obo/MONDO_0015758) (primary cutaneous T-cell lymphoma), [MONDO:0002207](http://purl.obolibrary.org/obo/MONDO_0002207) (vulval Paget's disease), [MONDO:0004988](http://purl.obolibrary.org/obo/MONDO_0004988) (breast adenocarcinoma), [MONDO:0006804](http://purl.obolibrary.org/obo/MONDO_0006804) (inflammatory breast carcinoma), [MONDO:0002206](http://purl.obolibrary.org/obo/MONDO_0002206) (sweat gland cancer), [MONDO:0003414](http://purl.obolibrary.org/obo/MONDO_0003414) (skin pilomatrix carcinoma), [MONDO:0003532](http://purl.obolibrary.org/obo/MONDO_0003532) (breast papillary carcinoma), [MONDO:0004984](http://purl.obolibrary.org/obo/MONDO_0004984) (basal-like breast carcinoma), [MONDO:0004621](http://purl.obolibrary.org/obo/MONDO_0004621) (upper lip cancer), [MONDO:0003530](http://purl.obolibrary.org/obo/MONDO_0003530) (aggressive digital papillary adenocarcinoma), [MONDO:0003531](http://purl.obolibrary.org/obo/MONDO_0003531) (eccrine papillary adenocarcinoma), [MONDO:0001470](http://purl.obolibrary.org/obo/MONDO_0001470) (anal margin squamous cell carcinoma), [MONDO:0006245](http://purl.obolibrary.org/obo/MONDO_0006245) (hidradenocarcinoma), [MONDO:0003091](http://purl.obolibrary.org/obo/MONDO_0003091) (cutaneous mucoepidermoid carcinoma), [MONDO:0017598](http://purl.obolibrary.org/obo/MONDO_0017598) (primary cutaneous anaplastic large cell lymphoma), [MONDO:0003747](http://purl.obolibrary.org/obo/MONDO_0003747) (telangiectatic glomangioma), [MONDO:0002655](http://purl.obolibrary.org/obo/MONDO_0002655) (cutaneous Paget's disease), [MONDO:0003624](http://purl.obolibrary.org/obo/MONDO_0003624) (acinic cell breast carcinoma), [MONDO:0004953](http://purl.obolibrary.org/obo/MONDO_0004953) (invasive ductal carcinoma), [MONDO:0002898](http://purl.obolibrary.org/obo/MONDO_0002898) (skin cancer), [MONDO:0002656](http://purl.obolibrary.org/obo/MONDO_0002656) (skin carcinoma), [MONDO:0003865](http://purl.obolibrary.org/obo/MONDO_0003865) (acral lentiginous melanoma (disease)), [MONDO:0002651](http://purl.obolibrary.org/obo/MONDO_0002651) (anal Paget's disease), [MONDO:0002653](http://purl.obolibrary.org/obo/MONDO_0002653) (Paget disease of the penis), [MONDO:0003187](http://purl.obolibrary.org/obo/MONDO_0003187) (Bartholin's gland adenoid cystic carcinoma), [MONDO:0011934](http://purl.obolibrary.org/obo/MONDO_0011934) (dermatofibrosarcoma protuberans), [MONDO:0003180](http://purl.obolibrary.org/obo/MONDO_0003180) (cutaneous adenocystic carcinoma), [MONDO:0000928](http://purl.obolibrary.org/obo/MONDO_0000928) (eyelid melanoma), [MONDO:0000929](http://purl.obolibrary.org/obo/MONDO_0000929) (balloon cell malignant melanoma), [MONDO:0003519](http://purl.obolibrary.org/obo/MONDO_0003519) (malignant syringoma), [MONDO:0003635](http://purl.obolibrary.org/obo/MONDO_0003635) (sebaceous breast carcinoma), [MONDO:0003876](http://purl.obolibrary.org/obo/MONDO_0003876) (eyelid carcinoma), [MONDO:0004288](http://purl.obolibrary.org/obo/MONDO_0004288) (scirrhous breast carcinoma), [MONDO:0005012](http://purl.obolibrary.org/obo/MONDO_0005012) (cutaneous melanoma (disease)), [MONDO:0004283](http://purl.obolibrary.org/obo/MONDO_0004283) (vulvar clear cell hidradenocarcinoma), [MONDO:0004281](http://purl.obolibrary.org/obo/MONDO_0004281) (vulvar eccrine porocarcinoma), [MONDO:0019476](http://purl.obolibrary.org/obo/MONDO_0019476) (primary cutaneous peripheral T-cell lymphoma not otherwise specified), [MONDO:0001702](http://purl.obolibrary.org/obo/MONDO_0001702) (labia majora carcinoma), [MONDO:0019475](http://purl.obolibrary.org/obo/MONDO_0019475) (subcutaneous panniculitis-like T-cell lymphoma), [MONDO:0003208](http://purl.obolibrary.org/obo/MONDO_0003208) (breast secretory carcinoma), [MONDO:0021313](http://purl.obolibrary.org/obo/MONDO_0021313) (eyelid cancer), [MONDO:0019472](http://purl.obolibrary.org/obo/MONDO_0019472) (extranodal nasal NK/T cell lymphoma), [MONDO:0006717](http://purl.obolibrary.org/obo/MONDO_0006717) (cutaneous fibrous histiocytoma), [MONDO:0019471](http://purl.obolibrary.org/obo/MONDO_0019471) (adult T-cell leukemia/lymphoma), [MONDO:0005506](http://purl.obolibrary.org/obo/MONDO_0005506) (eccrine sweat gland cancer), [MONDO:0003207](http://purl.obolibrary.org/obo/MONDO_0003207) (eccrine adenocarcinoma), [MONDO:0006834](http://purl.obolibrary.org/obo/MONDO_0006834) (lip cancer), [MONDO:0004412](http://purl.obolibrary.org/obo/MONDO_0004412) (malignant spiradenoma), [MONDO:0005063](http://purl.obolibrary.org/obo/MONDO_0005063) (medullary breast carcinoma), [MONDO:0005060](http://purl.obolibrary.org/obo/MONDO_0005060) (liposarcoma), [MONDO:0006270](http://purl.obolibrary.org/obo/MONDO_0006270) (lobular breast carcinoma in situ), [MONDO:0004091](http://purl.obolibrary.org/obo/MONDO_0004091) (basaloid squamous cell skin carcinoma), [MONDO:0017844](http://purl.obolibrary.org/obo/MONDO_0017844) (Sezary syndrome), [MONDO:0019467](http://purl.obolibrary.org/obo/MONDO_0019467) (CD4+/CD56+ hematodermic neoplasm), [MONDO:0004429](http://purl.obolibrary.org/obo/MONDO_0004429) (skin meningioma), [MONDO:0003215](http://purl.obolibrary.org/obo/MONDO_0003215) (apocrine sweat gland cancer), [MONDO:0021424](http://purl.obolibrary.org/obo/MONDO_0021424) (hemangiopericytoma of skin), [MONDO:0021427](http://purl.obolibrary.org/obo/MONDO_0021427) (squamous cell carcinoma of lip), [MONDO:0003214](http://purl.obolibrary.org/obo/MONDO_0003214) (apocrine adenocarcinoma), [MONDO:0006962](http://purl.obolibrary.org/obo/MONDO_0006962) (sebaceous adenocarcinoma), [MONDO:0004420](http://purl.obolibrary.org/obo/MONDO_0004420) (breast malignant eccrine spiradenoma), [MONDO:0010535](http://purl.obolibrary.org/obo/MONDO_0010535) (Bazex-DuprC)-Christol syndrome), [MONDO:0019210](http://purl.obolibrary.org/obo/MONDO_0019210) (cutaneous neuroendocrine carcinoma), [MONDO:0020562](http://purl.obolibrary.org/obo/MONDO_0020562) (pleomorphic liposarcoma), [MONDO:0020563](http://purl.obolibrary.org/obo/MONDO_0020563) (Dedifferentiated liposarcoma), [MONDO:0004636](http://purl.obolibrary.org/obo/MONDO_0004636) (lip carcinoma in situ), [MONDO:0020326](http://purl.obolibrary.org/obo/MONDO_0020326) (lymphomatoid papulosis), [MONDO:0004510](http://purl.obolibrary.org/obo/MONDO_0004510) (inflammatory liposarcoma), [MONDO:0020561](http://purl.obolibrary.org/obo/MONDO_0020561) (myxoid/round cell liposarcoma), [MONDO:0013101](http://purl.obolibrary.org/obo/MONDO_0013101) (BCC2), [MONDO:0013102](http://purl.obolibrary.org/obo/MONDO_0013102) (BCC3), [MONDO:0004523](http://purl.obolibrary.org/obo/MONDO_0004523) (clear cell squamous cell skin carcinoma), [MONDO:0003555](http://purl.obolibrary.org/obo/MONDO_0003555) (Bartholin's gland adenosquamous carcinoma), [MONDO:0004641](http://purl.obolibrary.org/obo/MONDO_0004641) (skin carcinoma in situ), [MONDO:0006383](http://purl.obolibrary.org/obo/MONDO_0006383) (primary cutaneous diffuse large B-cell lymphoma, leg type), [MONDO:0004083](http://purl.obolibrary.org/obo/MONDO_0004083) (Borst-Jadassohn intraepidermal carcinoma), [MONDO:0005051](http://purl.obolibrary.org/obo/MONDO_0005051) (invasive lobular carcinoma), [MONDO:0013104](http://purl.obolibrary.org/obo/MONDO_0013104) (BCC4), [MONDO:0013105](http://purl.obolibrary.org/obo/MONDO_0013105) (BCC5), [MONDO:0005050](http://purl.obolibrary.org/obo/MONDO_0005050) (invasive ductal and lobular carcinoma), [MONDO:0013106](http://purl.obolibrary.org/obo/MONDO_0013106) (BCC6), [MONDO:0002956](http://purl.obolibrary.org/obo/MONDO_0002956) (skin cystic basal cell carcinoma), [MONDO:0002955](http://purl.obolibrary.org/obo/MONDO_0002955) (vulva basal cell carcinoma), [MONDO:0002958](http://purl.obolibrary.org/obo/MONDO_0002958) (signet ring basal cell carcinoma), [MONDO:0003802](http://purl.obolibrary.org/obo/MONDO_0003802) (cornea cancer), [MONDO:0002957](http://purl.obolibrary.org/obo/MONDO_0002957) (sarcomatoid basal cell carcinoma), [MONDO:0002952](http://purl.obolibrary.org/obo/MONDO_0002952) (follicular basal cell carcinoma), [MONDO:0002951](http://purl.obolibrary.org/obo/MONDO_0002951) (skin adenoid basal cell carcinoma), [MONDO:0004337](http://purl.obolibrary.org/obo/MONDO_0004337) (perianal skin Paget's disease), [MONDO:0002954](http://purl.obolibrary.org/obo/MONDO_0002954) (superficial basal cell carcinoma), [MONDO:0002953](http://purl.obolibrary.org/obo/MONDO_0002953) (skin infiltrative basal cell carcinoma), [MONDO:0001740](http://purl.obolibrary.org/obo/MONDO_0001740) (cornea squamous cell carcinoma), [MONDO:0002950](http://purl.obolibrary.org/obo/MONDO_0002950) (skin clear cell basal cell carcinoma), [MONDO:0003363](http://purl.obolibrary.org/obo/MONDO_0003363) (malignant dermis tumor), [MONDO:0003362](http://purl.obolibrary.org/obo/MONDO_0003362) (cutaneous leiomyosarcoma (disease)), [MONDO:0011556](http://purl.obolibrary.org/obo/MONDO_0011556) (BCC1), [MONDO:0003936](http://purl.obolibrary.org/obo/MONDO_0003936) (invasive tubular breast carcinoma), [MONDO:0013280](http://purl.obolibrary.org/obo/MONDO_0013280) (myxoid liposarcoma), [MONDO:0003934](http://purl.obolibrary.org/obo/MONDO_0003934) (breast apocrine carcinoma), [MONDO:0021588](http://purl.obolibrary.org/obo/MONDO_0021588) (eyelid sebaceous gland carcinoma), [MONDO:0002726](http://purl.obolibrary.org/obo/MONDO_0002726) (cutaneous solitary mastocytoma), [MONDO:0003935](http://purl.obolibrary.org/obo/MONDO_0003935) (oncocytic breast carcinoma), [MONDO:0004469](http://purl.obolibrary.org/obo/MONDO_0004469) (pseudovascular skin squamous cell carcinoma), [MONDO:0003499](http://purl.obolibrary.org/obo/MONDO_0003499) (sarcomatoid squamous cell skin carcinoma), [MONDO:0004468](http://purl.obolibrary.org/obo/MONDO_0004468) (anal canal Paget's disease), [MONDO:0006402](http://purl.obolibrary.org/obo/MONDO_0006402) (salivary gland basal cell adenocarcinoma), [MONDO:0009691](http://purl.obolibrary.org/obo/MONDO_0009691) (mycosis fungoides), [MONDO:0003909](http://purl.obolibrary.org/obo/MONDO_0003909) (Bartholin's gland adenomyoma), [MONDO:0002938](http://purl.obolibrary.org/obo/MONDO_0002938) (metatypical basal cell carcinoma), [MONDO:0002937](http://purl.obolibrary.org/obo/MONDO_0002937) (nodular basal cell carcinoma), [MONDO:0002939](http://purl.obolibrary.org/obo/MONDO_0002939) (skin pigmented basal cell carcinoma), [MONDO:0021333](http://purl.obolibrary.org/obo/MONDO_0021333) (carcinoma of lip), [MONDO:0001602](http://purl.obolibrary.org/obo/MONDO_0001602) (labia minora carcinoma), [MONDO:0002936](http://purl.obolibrary.org/obo/MONDO_0002936) (scrotum basal cell carcinoma), [MONDO:0002935](http://purl.obolibrary.org/obo/MONDO_0002935) (penis basal cell carcinoma), [MONDO:0006738](http://purl.obolibrary.org/obo/MONDO_0006738) (eccrine acrospiroma), [MONDO:0004436](http://purl.obolibrary.org/obo/MONDO_0004436) (myxoid liposarcoma of the ovary), [MONDO:0003589](http://purl.obolibrary.org/obo/MONDO_0003589) (liposarcoma of the ovary), [MONDO:0004316](http://purl.obolibrary.org/obo/MONDO_0004316) (acantholytic squamous cell skin carcinoma), [MONDO:0003587](http://purl.obolibrary.org/obo/MONDO_0003587) (pediatric liposarcoma), [MONDO:0003588](http://purl.obolibrary.org/obo/MONDO_0003588) (larynx liposarcoma), [MONDO:0004314](http://purl.obolibrary.org/obo/MONDO_0004314) (malignant cutaneous granular cell skin tumor), [MONDO:0005524](http://purl.obolibrary.org/obo/MONDO_0005524) (sweat gland carcinoma), [MONDO:0003585](http://purl.obolibrary.org/obo/MONDO_0003585) (adult liposarcoma), [MONDO:0006973](http://purl.obolibrary.org/obo/MONDO_0006973) (skin appendage carcinoma), [MONDO:0003586](http://purl.obolibrary.org/obo/MONDO_0003586) (esophagus liposarcoma), [MONDO:0003341](http://purl.obolibrary.org/obo/MONDO_0003341) (subungual glomus tumor), [MONDO:0004673](http://purl.obolibrary.org/obo/MONDO_0004673) (lower lip cancer), [MONDO:0004550](http://purl.obolibrary.org/obo/MONDO_0004550) (malignant cornea melanoma), [MONDO:0006050](http://purl.obolibrary.org/obo/MONDO_0006050) (pleomorphic breast carcinoma), [MONDO:0002707](http://purl.obolibrary.org/obo/MONDO_0002707) (breast mucinous carcinoma), [MONDO:0002828](http://purl.obolibrary.org/obo/MONDO_0002828) (Bartholin's gland transitional cell carcinoma), [MONDO:0002949](http://purl.obolibrary.org/obo/MONDO_0002949) (morpheaform basal cell carcinoma), [MONDO:0002948](http://purl.obolibrary.org/obo/MONDO_0002948) (skin fibroepithelial basal cell carcinoma), [MONDO:0002829](http://purl.obolibrary.org/obo/MONDO_0002829) (Bartholin's gland carcinoma), [MONDO:0002945](http://purl.obolibrary.org/obo/MONDO_0002945) (micronodular basal cell carcinoma), [MONDO:0018031](http://purl.obolibrary.org/obo/MONDO_0018031) (granulomatous slack skin), [MONDO:0002947](http://purl.obolibrary.org/obo/MONDO_0002947) (adamantinoid basal cell epithelioma), [MONDO:0002705](http://purl.obolibrary.org/obo/MONDO_0002705) (breast mucinous cystadenocarcinoma), [MONDO:0002941](http://purl.obolibrary.org/obo/MONDO_0002941) (anal margin carcinoma), [MONDO:0002940](http://purl.obolibrary.org/obo/MONDO_0002940) (anal margin basal cell carcinoma), [MONDO:0002943](http://purl.obolibrary.org/obo/MONDO_0002943) (external ear basal cell carcinoma), [MONDO:0002942](http://purl.obolibrary.org/obo/MONDO_0002942) (sebaceous basal cell carcinoma), [MONDO:0003599](http://purl.obolibrary.org/obo/MONDO_0003599) (vulvar liposarcoma), [MONDO:0003596](http://purl.obolibrary.org/obo/MONDO_0003596) (spindle cell liposarcoma), [MONDO:0006622](http://purl.obolibrary.org/obo/MONDO_0006622) (vulvar seborrheic keratosis), [MONDO:0006621](http://purl.obolibrary.org/obo/MONDO_0006621) (vulvar inverted follicular keratosis), [MONDO:0003597](http://purl.obolibrary.org/obo/MONDO_0003597) (mixed-type liposarcoma), [MONDO:0002141](http://purl.obolibrary.org/obo/MONDO_0002141) (cutaneous undifferentiated pleomorphic sarcoma), [MONDO:0003594](http://purl.obolibrary.org/obo/MONDO_0003594) (mixed liposarcoma), [MONDO:0003592](http://purl.obolibrary.org/obo/MONDO_0003592) (gastric liposarcoma), [MONDO:0006189](http://purl.obolibrary.org/obo/MONDO_0006189) (eccrine porocarcinoma), [MONDO:0003593](http://purl.obolibrary.org/obo/MONDO_0003593) (breast liposarcoma), [MONDO:0003590](http://purl.obolibrary.org/obo/MONDO_0003590) (fibroblastic liposarcoma), [MONDO:0003591](http://purl.obolibrary.org/obo/MONDO_0003591) (kidney liposarcoma), [MONDO:0006184](http://purl.obolibrary.org/obo/MONDO_0006184) (ductal breast carcinoma in situ and lobular carcinoma in situ), [MONDO:0003602](http://purl.obolibrary.org/obo/MONDO_0003602) (intracranial liposarcoma), [MONDO:0003600](http://purl.obolibrary.org/obo/MONDO_0003600) (cutaneous liposarcoma), [MONDO:0002634](http://purl.obolibrary.org/obo/MONDO_0002634) (liposarcoma of bone), [MONDO:0003601](http://purl.obolibrary.org/obo/MONDO_0003601) (mediastinum liposarcoma), [MONDO:0005103](http://purl.obolibrary.org/obo/MONDO_0005103) (well-differentiated liposarcoma), [MONDO:0005341](http://purl.obolibrary.org/obo/MONDO_0005341) (skin basal cell carcinoma), [MONDO:0015820](http://purl.obolibrary.org/obo/MONDO_0015820) (primary cutaneous b-cell lymphoma), [MONDO:0018897](http://purl.obolibrary.org/obo/MONDO_0018897) (primary cutaneous CD30+ T-cell lymphoproliferative disease), [MONDO:0018898](http://purl.obolibrary.org/obo/MONDO_0018898) (primary cutaneous lymphoma), [MONDO:0008177](http://purl.obolibrary.org/obo/MONDO_0008177) (extramammary Paget disease), [MONDO:0002648](http://purl.obolibrary.org/obo/MONDO_0002648) (mammary Paget's disease), [MONDO:0002529](http://purl.obolibrary.org/obo/MONDO_0002529) (skin squamous cell carcinoma), [MONDO:0002765](http://purl.obolibrary.org/obo/MONDO_0002765) (plantar verrucous skin carcinoma), [MONDO:0003853](http://purl.obolibrary.org/obo/MONDO_0003853) (Bartholin's gland adenocarcinoma), [MONDO:0006327](http://purl.obolibrary.org/obo/MONDO_0006327) (ocular sebaceous carcinoma), [MONDO:0004269](http://purl.obolibrary.org/obo/MONDO_0004269) (breast cystic hypersecretory carcinoma), [MONDO:0005238](http://purl.obolibrary.org/obo/MONDO_0005238) (round cell liposarcoma), [MONDO:0020175](http://purl.obolibrary.org/obo/MONDO_0020175) (malignant tumor of palpebral epidermis), [MONDO:0005590](http://purl.obolibrary.org/obo/MONDO_0005590) (breast ductal adenocarcinoma), [MONDO:0011465](http://purl.obolibrary.org/obo/MONDO_0011465) (infundibulocystic basal cell carcinoma), [MONDO:0015821](http://purl.obolibrary.org/obo/MONDO_0015821) (mycosis fungoides and variants), [MONDO:0010017](http://purl.obolibrary.org/obo/MONDO_0010017) (sea-blue histiocyte syndrome), [MONDO:0001526](http://purl.obolibrary.org/obo/MONDO_0001526) (labia minora cancer), [MONDO:0005208](http://purl.obolibrary.org/obo/MONDO_0005208) (amelanotic skin melanoma), [MONDO:0003029](http://purl.obolibrary.org/obo/MONDO_0003029) (skin angiosarcoma), [MONDO:0001403](http://purl.obolibrary.org/obo/MONDO_0001403) (labium majus cancer), [MONDO:0006414](http://purl.obolibrary.org/obo/MONDO_0006414) (skin sarcoma), [MONDO:0002298](http://purl.obolibrary.org/obo/MONDO_0002298) (skin glomangioma), [MONDO:0000552](http://purl.obolibrary.org/obo/MONDO_0000552) (breast lobular carcinoma), [MONDO:0002295](http://purl.obolibrary.org/obo/MONDO_0002295) (skin glomus tumor), [MONDO:0021010](http://purl.obolibrary.org/obo/MONDO_0021010) (skin lymphangiosarcoma), [MONDO:0015819](http://purl.obolibrary.org/obo/MONDO_0015819) (indolent primary cutaneous b-cell lymphoma), [MONDO:0015818](http://purl.obolibrary.org/obo/MONDO_0015818) (aggressive primary cutaneous b-cell lymphoma), [MONDO:0004472](http://purl.obolibrary.org/obo/MONDO_0004472) (breast columnar cell mucinous carcinoma), [MONDO:0003264](http://purl.obolibrary.org/obo/MONDO_0003264) (basosquamous carcinoma), [MONDO:0007187](http://purl.obolibrary.org/obo/MONDO_0007187) (nevoid basal cell carcinoma syndrome), [MONDO:0006098](http://purl.obolibrary.org/obo/MONDO_0006098) (atypical lobular breast hyperplasia), [MONDO:0015814](http://purl.obolibrary.org/obo/MONDO_0015814) (primary cutaneous follicle center lymphoma), [MONDO:0015817](http://purl.obolibrary.org/obo/MONDO_0015817) (aggressive primary cutaneous T-cell lymphoma), [MONDO:0015816](http://purl.obolibrary.org/obo/MONDO_0015816) (indolent primary cutaneous T-cell lymphoma), [MONDO:0015811](http://purl.obolibrary.org/obo/MONDO_0015811) (primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma), [MONDO:0015810](http://purl.obolibrary.org/obo/MONDO_0015810) (primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma), [MONDO:0013876](http://purl.obolibrary.org/obo/MONDO_0013876) (basal cell carcinoma, susceptibility to, 7), [MONDO:0015813](http://purl.obolibrary.org/obo/MONDO_0015813) (primary cutaneous marginal zone b-cell lymphoma), [MONDO:0015812](http://purl.obolibrary.org/obo/MONDO_0015812) (primary cutaneous gamma/delta-positive T-cell lymphoma), [MONDO:0001778](http://purl.obolibrary.org/obo/MONDO_0001778) (dermoid cyst of skin), [MONDO:0001653](http://purl.obolibrary.org/obo/MONDO_0001653) (prepuce cancer), [MONDO:0006306](http://purl.obolibrary.org/obo/MONDO_0006306) (mixed lobular and ductal breast carcinoma), [MONDO:0015808](http://purl.obolibrary.org/obo/MONDO_0015808) (folliculotropic mycosis fungoides), [MONDO:0004120](http://purl.obolibrary.org/obo/MONDO_0004120) (Bartholin's gland small cell carcinoma), [MONDO:0015809](http://purl.obolibrary.org/obo/MONDO_0015809) (localized pagetoid reticulosis), [MONDO:0003390](http://purl.obolibrary.org/obo/MONDO_0003390) (glycogen-rich clear cell breast carcinoma), 

**Mapped go classes:** [GO:0016525](http://purl.obolibrary.org/obo/GO_0016525) (negative regulation of angiogenesis), [GO:0030031](http://purl.obolibrary.org/obo/GO_0030031) (cell projection assembly), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0003690](http://purl.obolibrary.org/obo/GO_0003690) (double-stranded DNA binding), [GO:0021798](http://purl.obolibrary.org/obo/GO_0021798) (forebrain dorsal/ventral pattern formation), [GO:0043588](http://purl.obolibrary.org/obo/GO_0043588) (skin development), [GO:0005874](http://purl.obolibrary.org/obo/GO_0005874) (microtubule), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0005628](http://purl.obolibrary.org/obo/GO_0005628) (prospore membrane), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0001947](http://purl.obolibrary.org/obo/GO_0001947) (heart looping), [GO:0050679](http://purl.obolibrary.org/obo/GO_0050679) (positive regulation of epithelial cell proliferation), [GO:0001709](http://purl.obolibrary.org/obo/GO_0001709) (cell fate determination), [GO:0031235](http://purl.obolibrary.org/obo/GO_0031235) (intrinsic component of the cytoplasmic side of the plasma membrane), [GO:2000491](http://purl.obolibrary.org/obo/GO_2000491) (positive regulation of hepatic stellate cell activation), [GO:0019901](http://purl.obolibrary.org/obo/GO_0019901) (protein kinase binding), [GO:0036488](http://purl.obolibrary.org/obo/GO_0036488) (CHOP-C/EBP complex), [GO:0036120](http://purl.obolibrary.org/obo/GO_0036120) (cellular response to platelet-derived growth factor stimulus), [GO:0048008](http://purl.obolibrary.org/obo/GO_0048008) (platelet-derived growth factor receptor signaling pathway), [GO:0035270](http://purl.obolibrary.org/obo/GO_0035270) (endocrine system development), [GO:0021782](http://purl.obolibrary.org/obo/GO_0021782) (glial cell development), [GO:0044325](http://purl.obolibrary.org/obo/GO_0044325) (ion channel binding), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0000077](http://purl.obolibrary.org/obo/GO_0000077) (DNA damage checkpoint), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0005518](http://purl.obolibrary.org/obo/GO_0005518) (collagen binding), [GO:0001953](http://purl.obolibrary.org/obo/GO_0001953) (negative regulation of cell-matrix adhesion), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0071363](http://purl.obolibrary.org/obo/GO_0071363) (cellular response to growth factor stimulus), [GO:0048013](http://purl.obolibrary.org/obo/GO_0048013) (ephrin receptor signaling pathway), [GO:0071364](http://purl.obolibrary.org/obo/GO_0071364) (cellular response to epidermal growth factor stimulus), [GO:0001957](http://purl.obolibrary.org/obo/GO_0001957) (intramembranous ossification), [GO:0010544](http://purl.obolibrary.org/obo/GO_0010544) (negative regulation of platelet activation), [GO:0031102](http://purl.obolibrary.org/obo/GO_0031102) (neuron projection regeneration), [GO:0001839](http://purl.obolibrary.org/obo/GO_0001839) (neural plate morphogenesis), [GO:0035143](http://purl.obolibrary.org/obo/GO_0035143) (caudal fin morphogenesis), [GO:0021537](http://purl.obolibrary.org/obo/GO_0021537) (telencephalon development), [GO:0021775](http://purl.obolibrary.org/obo/GO_0021775) (smoothened signaling pathway involved in ventral spinal cord interneuron specification), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0045786](http://purl.obolibrary.org/obo/GO_0045786) (negative regulation of cell cycle), [GO:0021776](http://purl.obolibrary.org/obo/GO_0021776) (smoothened signaling pathway involved in spinal cord motor neuron cell fate specification), [GO:0045787](http://purl.obolibrary.org/obo/GO_0045787) (positive regulation of cell cycle), [GO:0097193](http://purl.obolibrary.org/obo/GO_0097193) (intrinsic apoptotic signaling pathway), [GO:0009411](http://purl.obolibrary.org/obo/GO_0009411) (response to UV), [GO:1904754](http://purl.obolibrary.org/obo/GO_1904754) (positive regulation of vascular associated smooth muscle cell migration), [GO:0007596](http://purl.obolibrary.org/obo/GO_0007596) (blood coagulation), [GO:0021536](http://purl.obolibrary.org/obo/GO_0021536) (diencephalon development), [GO:0042157](http://purl.obolibrary.org/obo/GO_0042157) (lipoprotein metabolic process), [GO:0042159](http://purl.obolibrary.org/obo/GO_0042159) (lipoprotein catabolic process), [GO:0043249](http://purl.obolibrary.org/obo/GO_0043249) (erythrocyte maturation), [GO:1990782](http://purl.obolibrary.org/obo/GO_1990782) (protein tyrosine kinase binding), [GO:0060947](http://purl.obolibrary.org/obo/GO_0060947) (cardiac vascular smooth muscle cell differentiation), [GO:0051781](http://purl.obolibrary.org/obo/GO_0051781) (positive regulation of cell division), [GO:0051782](http://purl.obolibrary.org/obo/GO_0051782) (negative regulation of cell division), [GO:0048146](http://purl.obolibrary.org/obo/GO_0048146) (positive regulation of fibroblast proliferation), [GO:0043010](http://purl.obolibrary.org/obo/GO_0043010) (camera-type eye development), [GO:0010512](http://purl.obolibrary.org/obo/GO_0010512) (negative regulation of phosphatidylinositol biosynthetic process), [GO:0072126](http://purl.obolibrary.org/obo/GO_0072126) (positive regulation of glomerular mesangial cell proliferation), [GO:0031578](http://purl.obolibrary.org/obo/GO_0031578) (mitotic spindle orientation checkpoint), [GO:2000379](http://purl.obolibrary.org/obo/GO_2000379) (positive regulation of reactive oxygen species metabolic process), [GO:0019900](http://purl.obolibrary.org/obo/GO_0019900) (kinase binding), [GO:0010873](http://purl.obolibrary.org/obo/GO_0010873) (positive regulation of cholesterol esterification), [GO:1905176](http://purl.obolibrary.org/obo/GO_1905176) (positive regulation of vascular smooth muscle cell dedifferentiation), [GO:0007120](http://purl.obolibrary.org/obo/GO_0007120) (axial cellular bud site selection), [GO:0007121](http://purl.obolibrary.org/obo/GO_0007121) (bipolar cellular bud site selection), [GO:0031571](http://purl.obolibrary.org/obo/GO_0031571) (mitotic G1 DNA damage checkpoint), [GO:0048702](http://purl.obolibrary.org/obo/GO_0048702) (embryonic neurocranium morphogenesis), [GO:0021522](http://purl.obolibrary.org/obo/GO_0021522) (spinal cord motor neuron differentiation), [GO:0021523](http://purl.obolibrary.org/obo/GO_0021523) (somatic motor neuron differentiation), [GO:0006275](http://purl.obolibrary.org/obo/GO_0006275) (regulation of DNA replication), [GO:0048821](http://purl.obolibrary.org/obo/GO_0048821) (erythrocyte development), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0003684](http://purl.obolibrary.org/obo/GO_0003684) (damaged DNA binding), [GO:0021520](http://purl.obolibrary.org/obo/GO_0021520) (spinal cord motor neuron cell fate specification), [GO:0007368](http://purl.obolibrary.org/obo/GO_0007368) (determination of left/right symmetry), [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis), [GO:0046889](http://purl.obolibrary.org/obo/GO_0046889) (positive regulation of lipid biosynthetic process), [GO:0030239](http://purl.obolibrary.org/obo/GO_0030239) (myofibril assembly), [GO:0072593](http://purl.obolibrary.org/obo/GO_0072593) (reactive oxygen species metabolic process), [GO:0046890](http://purl.obolibrary.org/obo/GO_0046890) (regulation of lipid biosynthetic process), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0004888](http://purl.obolibrary.org/obo/GO_0004888) (transmembrane signaling receptor activity), [GO:0006707](http://purl.obolibrary.org/obo/GO_0006707) (cholesterol catabolic process), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0010526](http://purl.obolibrary.org/obo/GO_0010526) (negative regulation of transposition, RNA-mediated), [GO:0001934](http://purl.obolibrary.org/obo/GO_0001934) (positive regulation of protein phosphorylation), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0097756](http://purl.obolibrary.org/obo/GO_0097756) (negative regulation of blood vessel diameter), [GO:0001938](http://purl.obolibrary.org/obo/GO_0001938) (positive regulation of endothelial cell proliferation), [GO:0070059](http://purl.obolibrary.org/obo/GO_0070059) (intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress), [GO:0106003](http://purl.obolibrary.org/obo/GO_0106003) (amyloid-beta complex), [GO:0007050](http://purl.obolibrary.org/obo/GO_0007050) (cell cycle arrest), [GO:0045606](http://purl.obolibrary.org/obo/GO_0045606) (positive regulation of epidermal cell differentiation), [GO:0032374](http://purl.obolibrary.org/obo/GO_0032374) (regulation of cholesterol transport), [GO:0061098](http://purl.obolibrary.org/obo/GO_0061098) (positive regulation of protein tyrosine kinase activity), [GO:0008142](http://purl.obolibrary.org/obo/GO_0008142) (oxysterol binding), [GO:0042693](http://purl.obolibrary.org/obo/GO_0042693) (muscle cell fate commitment), [GO:0048557](http://purl.obolibrary.org/obo/GO_0048557) (embryonic digestive tract morphogenesis), [GO:0043422](http://purl.obolibrary.org/obo/GO_0043422) (protein kinase B binding), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0045840](http://purl.obolibrary.org/obo/GO_0045840) (positive regulation of mitotic nuclear division), [GO:0060445](http://purl.obolibrary.org/obo/GO_0060445) (branching involved in salivary gland morphogenesis), [GO:0043547](http://purl.obolibrary.org/obo/GO_0043547) (positive regulation of GTPase activity), [GO:0060326](http://purl.obolibrary.org/obo/GO_0060326) (cell chemotaxis), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0031954](http://purl.obolibrary.org/obo/GO_0031954) (positive regulation of protein autophosphorylation), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0002039](http://purl.obolibrary.org/obo/GO_0002039) (p53 binding), [GO:0050750](http://purl.obolibrary.org/obo/GO_0050750) (low-density lipoprotein particle receptor binding), [GO:0051289](http://purl.obolibrary.org/obo/GO_0051289) (protein homotetramerization), [GO:0005669](http://purl.obolibrary.org/obo/GO_0005669) (transcription factor TFIID complex), [GO:0033333](http://purl.obolibrary.org/obo/GO_0033333) (fin development), [GO:0071456](http://purl.obolibrary.org/obo/GO_0071456) (cellular response to hypoxia), [GO:0010332](http://purl.obolibrary.org/obo/GO_0010332) (response to gamma radiation), [GO:0045737](http://purl.obolibrary.org/obo/GO_0045737) (positive regulation of cyclin-dependent protein serine/threonine kinase activity), [GO:0014033](http://purl.obolibrary.org/obo/GO_0014033) (neural crest cell differentiation), [GO:0015485](http://purl.obolibrary.org/obo/GO_0015485) (cholesterol binding), [GO:0030182](http://purl.obolibrary.org/obo/GO_0030182) (neuron differentiation), [GO:1900221](http://purl.obolibrary.org/obo/GO_1900221) (regulation of amyloid-beta clearance), [GO:0042462](http://purl.obolibrary.org/obo/GO_0042462) (eye photoreceptor cell development), [GO:0043552](http://purl.obolibrary.org/obo/GO_0043552) (positive regulation of phosphatidylinositol 3-kinase activity), [GO:0008158](http://purl.obolibrary.org/obo/GO_0008158) (hedgehog receptor activity), [GO:0043433](http://purl.obolibrary.org/obo/GO_0043433) (negative regulation of DNA binding transcription factor activity), [GO:0045977](http://purl.obolibrary.org/obo/GO_0045977) (positive regulation of mitotic cell cycle, embryonic), [GO:0000785](http://purl.obolibrary.org/obo/GO_0000785) (chromatin), [GO:0021587](http://purl.obolibrary.org/obo/GO_0021587) (cerebellum morphogenesis), [GO:0042472](http://purl.obolibrary.org/obo/GO_0042472) (inner ear morphogenesis), [GO:0032474](http://purl.obolibrary.org/obo/GO_0032474) (otolith morphogenesis), [GO:0016322](http://purl.obolibrary.org/obo/GO_0016322) (neuron remodeling), [GO:0016323](http://purl.obolibrary.org/obo/GO_0016323) (basolateral plasma membrane), [GO:0030971](http://purl.obolibrary.org/obo/GO_0030971) (receptor tyrosine kinase binding), [GO:0014003](http://purl.obolibrary.org/obo/GO_0014003) (oligodendrocyte development), [GO:0090630](http://purl.obolibrary.org/obo/GO_0090630) (activation of GTPase activity), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:1902894](http://purl.obolibrary.org/obo/GO_1902894) (negative regulation of pri-miRNA transcription by RNA polymerase II), [GO:0005096](http://purl.obolibrary.org/obo/GO_0005096) (GTPase activator activity), [GO:0007399](http://purl.obolibrary.org/obo/GO_0007399) (nervous system development), [GO:0060228](http://purl.obolibrary.org/obo/GO_0060228) (phosphatidylcholine-sterol O-acyltransferase activator activity), [GO:0045743](http://purl.obolibrary.org/obo/GO_0045743) (positive regulation of fibroblast growth factor receptor signaling pathway), [GO:0045740](http://purl.obolibrary.org/obo/GO_0045740) (positive regulation of DNA replication), [GO:1902895](http://purl.obolibrary.org/obo/GO_1902895) (positive regulation of pri-miRNA transcription by RNA polymerase II), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0003231](http://purl.obolibrary.org/obo/GO_0003231) (cardiac ventricle development), [GO:0003104](http://purl.obolibrary.org/obo/GO_0003104) (positive regulation of glomerular filtration), [GO:0006978](http://purl.obolibrary.org/obo/GO_0006978) (DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator), [GO:0003347](http://purl.obolibrary.org/obo/GO_0003347) (epicardial cell to mesenchymal cell transition), [GO:0005769](http://purl.obolibrary.org/obo/GO_0005769) (early endosome), [GO:1904707](http://purl.obolibrary.org/obo/GO_1904707) (positive regulation of vascular smooth muscle cell proliferation), [GO:0043691](http://purl.obolibrary.org/obo/GO_0043691) (reverse cholesterol transport), [GO:0001843](http://purl.obolibrary.org/obo/GO_0001843) (neural tube closure), [GO:0072562](http://purl.obolibrary.org/obo/GO_0072562) (blood microparticle), [GO:0001726](http://purl.obolibrary.org/obo/GO_0001726) (ruffle), [GO:0035976](http://purl.obolibrary.org/obo/GO_0035976) (transcription factor AP-1 complex), [GO:0034644](http://purl.obolibrary.org/obo/GO_0034644) (cellular response to UV), [GO:2000298](http://purl.obolibrary.org/obo/GO_2000298) (regulation of Rho-dependent protein serine/threonine kinase activity), [GO:0031012](http://purl.obolibrary.org/obo/GO_0031012) (extracellular matrix), [GO:0014911](http://purl.obolibrary.org/obo/GO_0014911) (positive regulation of smooth muscle cell migration), [GO:0031017](http://purl.obolibrary.org/obo/GO_0031017) (exocrine pancreas development), [GO:0031018](http://purl.obolibrary.org/obo/GO_0031018) (endocrine pancreas development), [GO:0031016](http://purl.obolibrary.org/obo/GO_0031016) (pancreas development), [GO:2000059](http://purl.obolibrary.org/obo/GO_2000059) (negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0036267](http://purl.obolibrary.org/obo/GO_0036267) (invasive filamentous growth), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0007162](http://purl.obolibrary.org/obo/GO_0007162) (negative regulation of cell adhesion), [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis), [GO:0007163](http://purl.obolibrary.org/obo/GO_0007163) (establishment or maintenance of cell polarity), [GO:0007166](http://purl.obolibrary.org/obo/GO_0007166) (cell surface receptor signaling pathway), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0008013](http://purl.obolibrary.org/obo/GO_0008013) (beta-catenin binding), [GO:0042246](http://purl.obolibrary.org/obo/GO_0042246) (tissue regeneration), [GO:0005543](http://purl.obolibrary.org/obo/GO_0005543) (phospholipid binding), [GO:1900127](http://purl.obolibrary.org/obo/GO_1900127) (positive regulation of hyaluronan biosynthetic process), [GO:0045879](http://purl.obolibrary.org/obo/GO_0045879) (negative regulation of smoothened signaling pathway), [GO:0007049](http://purl.obolibrary.org/obo/GO_0007049) (cell cycle), [GO:0060216](http://purl.obolibrary.org/obo/GO_0060216) (definitive hemopoiesis), [GO:0030833](http://purl.obolibrary.org/obo/GO_0030833) (regulation of actin filament polymerization), [GO:0005657](http://purl.obolibrary.org/obo/GO_0005657) (replication fork), [GO:0006869](http://purl.obolibrary.org/obo/GO_0006869) (lipid transport), [GO:0042493](http://purl.obolibrary.org/obo/GO_0042493) (response to drug), [GO:0070374](http://purl.obolibrary.org/obo/GO_0070374) (positive regulation of ERK1 and ERK2 cascade), [GO:0045880](http://purl.obolibrary.org/obo/GO_0045880) (positive regulation of smoothened signaling pathway), [GO:0030036](http://purl.obolibrary.org/obo/GO_0030036) (actin cytoskeleton organization), [GO:0061298](http://purl.obolibrary.org/obo/GO_0061298) (retina vasculature development in camera-type eye), [GO:0014068](http://purl.obolibrary.org/obo/GO_0014068) (positive regulation of phosphatidylinositol 3-kinase signaling), [GO:0038033](http://purl.obolibrary.org/obo/GO_0038033) (positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway), [GO:0009952](http://purl.obolibrary.org/obo/GO_0009952) (anterior/posterior pattern specification), [GO:0048514](http://purl.obolibrary.org/obo/GO_0048514) (blood vessel morphogenesis), [GO:0007411](http://purl.obolibrary.org/obo/GO_0007411) (axon guidance), [GO:0048635](http://purl.obolibrary.org/obo/GO_0048635) (negative regulation of muscle organ development), [GO:0042771](http://purl.obolibrary.org/obo/GO_0042771) (intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator), [GO:1901621](http://purl.obolibrary.org/obo/GO_1901621) (negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning), [GO:0002088](http://purl.obolibrary.org/obo/GO_0002088) (lens development in camera-type eye), [GO:0005113](http://purl.obolibrary.org/obo/GO_0005113) (patched binding), [GO:0009954](http://purl.obolibrary.org/obo/GO_0009954) (proximal/distal pattern formation), [GO:0001784](http://purl.obolibrary.org/obo/GO_0001784) (phosphotyrosine residue binding), [GO:0030425](http://purl.obolibrary.org/obo/GO_0030425) (dendrite), [GO:0004930](http://purl.obolibrary.org/obo/GO_0004930) (G-protein coupled receptor activity), [GO:0005901](http://purl.obolibrary.org/obo/GO_0005901) (caveola), [GO:0032967](http://purl.obolibrary.org/obo/GO_0032967) (positive regulation of collagen biosynthetic process), [GO:0046580](http://purl.obolibrary.org/obo/GO_0046580) (negative regulation of Ras protein signal transduction), [GO:0001666](http://purl.obolibrary.org/obo/GO_0001666) (response to hypoxia), [GO:0051000](http://purl.obolibrary.org/obo/GO_0051000) (positive regulation of nitric-oxide synthase activity), [GO:0070326](http://purl.obolibrary.org/obo/GO_0070326) (very-low-density lipoprotein particle receptor binding), [GO:0035793](http://purl.obolibrary.org/obo/GO_0035793) (positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway), [GO:0031076](http://purl.obolibrary.org/obo/GO_0031076) (embryonic camera-type eye development), [GO:0035791](http://purl.obolibrary.org/obo/GO_0035791) (platelet-derived growth factor receptor-beta signaling pathway), [GO:0006695](http://purl.obolibrary.org/obo/GO_0006695) (cholesterol biosynthetic process), [GO:0048407](http://purl.obolibrary.org/obo/GO_0048407) (platelet-derived growth factor binding), [GO:0072175](http://purl.obolibrary.org/obo/GO_0072175) (epithelial tube formation), [GO:0007416](http://purl.obolibrary.org/obo/GO_0007416) (synapse assembly), [GO:0007417](http://purl.obolibrary.org/obo/GO_0007417) (central nervous system development), [GO:0005119](http://purl.obolibrary.org/obo/GO_0005119) (smoothened binding), [GO:0009957](http://purl.obolibrary.org/obo/GO_0009957) (epidermal cell fate specification), [GO:0051496](http://purl.obolibrary.org/obo/GO_0051496) (positive regulation of stress fiber assembly), [GO:0043087](http://purl.obolibrary.org/obo/GO_0043087) (regulation of GTPase activity), [GO:0035301](http://purl.obolibrary.org/obo/GO_0035301) (Hedgehog signaling complex), [GO:0043406](http://purl.obolibrary.org/obo/GO_0043406) (positive regulation of MAP kinase activity), [GO:0031065](http://purl.obolibrary.org/obo/GO_0031065) (positive regulation of histone deacetylation), [GO:0030097](http://purl.obolibrary.org/obo/GO_0030097) (hemopoiesis), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0090398](http://purl.obolibrary.org/obo/GO_0090398) (cellular senescence), [GO:0008289](http://purl.obolibrary.org/obo/GO_0008289) (lipid binding), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0060664](http://purl.obolibrary.org/obo/GO_0060664) (epithelial cell proliferation involved in salivary gland morphogenesis), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0001892](http://purl.obolibrary.org/obo/GO_0001892) (embryonic placenta development), [GO:0043525](http://purl.obolibrary.org/obo/GO_0043525) (positive regulation of neuron apoptotic process), [GO:0043524](http://purl.obolibrary.org/obo/GO_0043524) (negative regulation of neuron apoptotic process), [GO:0048661](http://purl.obolibrary.org/obo/GO_0048661) (positive regulation of smooth muscle cell proliferation), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0050730](http://purl.obolibrary.org/obo/GO_0050730) (regulation of peptidyl-tyrosine phosphorylation), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:2000779](http://purl.obolibrary.org/obo/GO_2000779) (regulation of double-strand break repair), [GO:0048663](http://purl.obolibrary.org/obo/GO_0048663) (neuron fate commitment), [GO:0051020](http://purl.obolibrary.org/obo/GO_0051020) (GTPase binding), [GO:0051262](http://purl.obolibrary.org/obo/GO_0051262) (protein tetramerization), [GO:0001649](http://purl.obolibrary.org/obo/GO_0001649) (osteoblast differentiation), [GO:0097108](http://purl.obolibrary.org/obo/GO_0097108) (hedgehog family protein binding), [GO:0032147](http://purl.obolibrary.org/obo/GO_0032147) (activation of protein kinase activity), [GO:0032148](http://purl.obolibrary.org/obo/GO_0032148) (activation of protein kinase B activity), [GO:0050731](http://purl.obolibrary.org/obo/GO_0050731) (positive regulation of peptidyl-tyrosine phosphorylation), [GO:0035655](http://purl.obolibrary.org/obo/GO_0035655) (interleukin-18-mediated signaling pathway), [GO:0071679](http://purl.obolibrary.org/obo/GO_0071679) (commissural neuron axon guidance), [GO:0031290](http://purl.obolibrary.org/obo/GO_0031290) (retinal ganglion cell axon guidance), [GO:0003281](http://purl.obolibrary.org/obo/GO_0003281) (ventricular septum development), [GO:0038001](http://purl.obolibrary.org/obo/GO_0038001) (paracrine signaling), [GO:0043410](http://purl.obolibrary.org/obo/GO_0043410) (positive regulation of MAPK cascade), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0060896](http://purl.obolibrary.org/obo/GO_0060896) (neural plate pattern specification), [GO:0043536](http://purl.obolibrary.org/obo/GO_0043536) (positive regulation of blood vessel endothelial cell migration), [GO:0001540](http://purl.obolibrary.org/obo/GO_0001540) (amyloid-beta binding), [GO:0090280](http://purl.obolibrary.org/obo/GO_0090280) (positive regulation of calcium ion import), [GO:0007517](http://purl.obolibrary.org/obo/GO_0007517) (muscle organ development), [GO:0031965](http://purl.obolibrary.org/obo/GO_0031965) (nuclear membrane), [GO:0030516](http://purl.obolibrary.org/obo/GO_0030516) (regulation of axon extension), [GO:0003714](http://purl.obolibrary.org/obo/GO_0003714) (transcription corepressor activity), [GO:0048795](http://purl.obolibrary.org/obo/GO_0048795) (swim bladder morphogenesis), [GO:0048794](http://purl.obolibrary.org/obo/GO_0048794) (swim bladder development), [GO:0033344](http://purl.obolibrary.org/obo/GO_0033344) (cholesterol efflux), [GO:0010002](http://purl.obolibrary.org/obo/GO_0010002) (cardioblast differentiation), [GO:1903392](http://purl.obolibrary.org/obo/GO_1903392) (negative regulation of adherens junction organization), [GO:0018108](http://purl.obolibrary.org/obo/GO_0018108) (peptidyl-tyrosine phosphorylation), [GO:0070528](http://purl.obolibrary.org/obo/GO_0070528) (protein kinase C signaling), [GO:0048839](http://purl.obolibrary.org/obo/GO_0048839) (inner ear development), [GO:0016604](http://purl.obolibrary.org/obo/GO_0016604) (nuclear body), [GO:0060041](http://purl.obolibrary.org/obo/GO_0060041) (retina development in camera-type eye), [GO:0060042](http://purl.obolibrary.org/obo/GO_0060042) (retina morphogenesis in camera-type eye), [GO:0060844](http://purl.obolibrary.org/obo/GO_0060844) (arterial endothelial cell fate commitment), [GO:0008544](http://purl.obolibrary.org/obo/GO_0008544) (epidermis development), [GO:1904899](http://purl.obolibrary.org/obo/GO_1904899) (positive regulation of hepatic stellate cell proliferation), [GO:0042056](http://purl.obolibrary.org/obo/GO_0042056) (chemoattractant activity), [GO:0021513](http://purl.obolibrary.org/obo/GO_0021513) (spinal cord dorsal/ventral patterning), [GO:0043025](http://purl.obolibrary.org/obo/GO_0043025) (neuronal cell body), [GO:0032091](http://purl.obolibrary.org/obo/GO_0032091) (negative regulation of protein binding), [GO:0072264](http://purl.obolibrary.org/obo/GO_0072264) (metanephric glomerular endothelium development), [GO:0072262](http://purl.obolibrary.org/obo/GO_0072262) (metanephric glomerular mesangial cell proliferation involved in metanephros development), [GO:0030900](http://purl.obolibrary.org/obo/GO_0030900) (forebrain development), [GO:0030902](http://purl.obolibrary.org/obo/GO_0030902) (hindbrain development), [GO:0060729](http://purl.obolibrary.org/obo/GO_0060729) (intestinal epithelial structure maintenance), [GO:0006914](http://purl.obolibrary.org/obo/GO_0006914) (autophagy), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0055002](http://purl.obolibrary.org/obo/GO_0055002) (striated muscle cell development), [GO:0016176](http://purl.obolibrary.org/obo/GO_0016176) (superoxide-generating NADPH oxidase activator activity), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0035912](http://purl.obolibrary.org/obo/GO_0035912) (dorsal aorta morphogenesis), [GO:1905064](http://purl.obolibrary.org/obo/GO_1905064) (negative regulation of vascular smooth muscle cell differentiation), [GO:0017147](http://purl.obolibrary.org/obo/GO_0017147) (Wnt-protein binding), [GO:0032403](http://purl.obolibrary.org/obo/GO_0032403) (protein complex binding), [GO:0035479](http://purl.obolibrary.org/obo/GO_0035479) (angioblast cell migration from lateral mesoderm to midline), [GO:0021508](http://purl.obolibrary.org/obo/GO_0021508) (floor plate formation), [GO:0042627](http://purl.obolibrary.org/obo/GO_0042627) (chylomicron), [GO:0034380](http://purl.obolibrary.org/obo/GO_0034380) (high-density lipoprotein particle assembly), [GO:0005161](http://purl.obolibrary.org/obo/GO_0005161) (platelet-derived growth factor receptor binding), [GO:0009880](http://purl.obolibrary.org/obo/GO_0009880) (embryonic pattern specification), [GO:0061484](http://purl.obolibrary.org/obo/GO_0061484) (hematopoietic stem cell homeostasis), [GO:0021984](http://purl.obolibrary.org/obo/GO_0021984) (adenohypophysis development), [GO:0007224](http://purl.obolibrary.org/obo/GO_0007224) (smoothened signaling pathway), [GO:0060956](http://purl.obolibrary.org/obo/GO_0060956) (endocardial cell differentiation), [GO:0060830](http://purl.obolibrary.org/obo/GO_0060830) (ciliary receptor clustering involved in smoothened signaling pathway), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0043280](http://purl.obolibrary.org/obo/GO_0043280) (positive regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0010629](http://purl.obolibrary.org/obo/GO_0010629) (negative regulation of gene expression), [GO:0035904](http://purl.obolibrary.org/obo/GO_0035904) (aorta development), [GO:0048730](http://purl.obolibrary.org/obo/GO_0048730) (epidermis morphogenesis), [GO:0072255](http://purl.obolibrary.org/obo/GO_0072255) (metanephric glomerular mesangial cell development), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0006929](http://purl.obolibrary.org/obo/GO_0006929) (substrate-dependent cell migration), [GO:1990617](http://purl.obolibrary.org/obo/GO_1990617) (CHOP-ATF4 complex), [GO:0019433](http://purl.obolibrary.org/obo/GO_0019433) (triglyceride catabolic process), [GO:0018105](http://purl.obolibrary.org/obo/GO_0018105) (peptidyl-serine phosphorylation), [GO:0050921](http://purl.obolibrary.org/obo/GO_0050921) (positive regulation of chemotaxis), [GO:0030336](http://purl.obolibrary.org/obo/GO_0030336) (negative regulation of cell migration), [GO:0030335](http://purl.obolibrary.org/obo/GO_0030335) (positive regulation of cell migration), [GO:0051216](http://purl.obolibrary.org/obo/GO_0051216) (cartilage development), [GO:0034372](http://purl.obolibrary.org/obo/GO_0034372) (very-low-density lipoprotein particle remodeling), [GO:0008083](http://purl.obolibrary.org/obo/GO_0008083) (growth factor activity), [GO:0010165](http://purl.obolibrary.org/obo/GO_0010165) (response to X-ray), [GO:0045907](http://purl.obolibrary.org/obo/GO_0045907) (positive regulation of vasoconstriction), [GO:0009611](http://purl.obolibrary.org/obo/GO_0009611) (response to wounding), [GO:0001570](http://purl.obolibrary.org/obo/GO_0001570) (vasculogenesis), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0042994](http://purl.obolibrary.org/obo/GO_0042994) (cytoplasmic sequestering of transcription factor), [GO:0042632](http://purl.obolibrary.org/obo/GO_0042632) (cholesterol homeostasis), [GO:0042633](http://purl.obolibrary.org/obo/GO_0042633) (hair cycle), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0030447](http://purl.obolibrary.org/obo/GO_0030447) (filamentous growth), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:0048741](http://purl.obolibrary.org/obo/GO_0048741) (skeletal muscle fiber development), [GO:1990622](http://purl.obolibrary.org/obo/GO_1990622) (CHOP-ATF3 complex), [GO:0005929](http://purl.obolibrary.org/obo/GO_0005929) (cilium), [GO:2000573](http://purl.obolibrary.org/obo/GO_2000573) (positive regulation of DNA biosynthetic process), [GO:0017127](http://purl.obolibrary.org/obo/GO_0017127) (cholesterol transporter activity), [GO:1902262](http://purl.obolibrary.org/obo/GO_1902262) (apoptotic process involved in blood vessel morphogenesis), [GO:2000591](http://purl.obolibrary.org/obo/GO_2000591) (positive regulation of metanephric mesenchymal cell migration), [GO:0034364](http://purl.obolibrary.org/obo/GO_0034364) (high-density lipoprotein particle), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0034363](http://purl.obolibrary.org/obo/GO_0034363) (intermediate-density lipoprotein particle), [GO:0060976](http://purl.obolibrary.org/obo/GO_0060976) (coronary vasculature development), [GO:0048745](http://purl.obolibrary.org/obo/GO_0048745) (smooth muscle tissue development), [GO:0046326](http://purl.obolibrary.org/obo/GO_0046326) (positive regulation of glucose import), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0060978](http://purl.obolibrary.org/obo/GO_0060978) (angiogenesis involved in coronary vascular morphogenesis), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0000131](http://purl.obolibrary.org/obo/GO_0000131) (incipient cellular bud site), [GO:0051597](http://purl.obolibrary.org/obo/GO_0051597) (response to methylmercury), [GO:0031647](http://purl.obolibrary.org/obo/GO_0031647) (regulation of protein stability), [GO:0002548](http://purl.obolibrary.org/obo/GO_0002548) (monocyte chemotaxis), [GO:0005935](http://purl.obolibrary.org/obo/GO_0005935) (cellular bud neck), [GO:0048752](http://purl.obolibrary.org/obo/GO_0048752) (semicircular canal morphogenesis), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0071506](http://purl.obolibrary.org/obo/GO_0071506) (cellular response to mycophenolic acid), [GO:0033700](http://purl.obolibrary.org/obo/GO_0033700) (phospholipid efflux), 

**Class expressions from DL-Learner:**

- Thing 57.73%
- [GO:0032505](http://purl.obolibrary.org/obo/GO_0032505) (reproduction of a single-celled organism) 50.68%
- [GO:0019954](http://purl.obolibrary.org/obo/GO_0019954) (asexual reproduction) 50.68%
- [GO:0007114](http://purl.obolibrary.org/obo/GO_0007114) (cell budding) 50.68%
- [GO:0032505](http://purl.obolibrary.org/obo/GO_0032505) (reproduction of a single-celled organism) and [GO:1903047](http://purl.obolibrary.org/obo/GO_1903047) (mitotic cell cycle process) 50.68%
- [GO:0032505](http://purl.obolibrary.org/obo/GO_0032505) (reproduction of a single-celled organism) and [GO:0051301](http://purl.obolibrary.org/obo/GO_0051301) (cell division) 50.68%
- [GO:0030010](http://purl.obolibrary.org/obo/GO_0030010) (establishment of cell polarity) and [GO:0032505](http://purl.obolibrary.org/obo/GO_0032505) (reproduction of a single-celled organism) 50.68%
- [GO:0022402](http://purl.obolibrary.org/obo/GO_0022402) (cell cycle process) and [GO:0032505](http://purl.obolibrary.org/obo/GO_0032505) (reproduction of a single-celled organism) 50.68%
- [GO:0019954](http://purl.obolibrary.org/obo/GO_0019954) (asexual reproduction) and [GO:1903047](http://purl.obolibrary.org/obo/GO_1903047) (mitotic cell cycle process) 50.68%
- [GO:0019954](http://purl.obolibrary.org/obo/GO_0019954) (asexual reproduction) and [GO:0051301](http://purl.obolibrary.org/obo/GO_0051301) (cell division) 50.68%
- [GO:0019954](http://purl.obolibrary.org/obo/GO_0019954) (asexual reproduction) and [GO:0032505](http://purl.obolibrary.org/obo/GO_0032505) (reproduction of a single-celled organism) 50.68%
- [GO:0019954](http://purl.obolibrary.org/obo/GO_0019954) (asexual reproduction) and [GO:0030010](http://purl.obolibrary.org/obo/GO_0030010) (establishment of cell polarity) 50.68%
- [GO:0019954](http://purl.obolibrary.org/obo/GO_0019954) (asexual reproduction) and [GO:0022402](http://purl.obolibrary.org/obo/GO_0022402) (cell cycle process) 50.68%
- [GO:0009987](http://purl.obolibrary.org/obo/GO_0009987) (cellular process) and [GO:0032505](http://purl.obolibrary.org/obo/GO_0032505) (reproduction of a single-celled organism) 50.68%
- [GO:0009987](http://purl.obolibrary.org/obo/GO_0009987) (cellular process) and [GO:0019954](http://purl.obolibrary.org/obo/GO_0019954) (asexual reproduction) 50.68%


